APA (7th ed.) Citation

A, D., AM, K., B, Y., HW, W., B, S., C, Y., . . . NN, S. (2026). Outcomes following CD22 CAR T-cells in B-ALL: A tale of two manufacturing strategies. Cytotherapy, 28(3), 101990. https://doi.org/10.1016/j.jcyt.2025.09.013

Chicago Style (17th ed.) Citation

A, Dreyzin, et al. "Outcomes Following CD22 CAR T-cells in B-ALL: A Tale of Two Manufacturing Strategies." Cytotherapy 28, no. 3 (2026): 101990. https://doi.org/10.1016/j.jcyt.2025.09.013.

MLA (9th ed.) Citation

A, Dreyzin, et al. "Outcomes Following CD22 CAR T-cells in B-ALL: A Tale of Two Manufacturing Strategies." Cytotherapy, vol. 28, no. 3, 2026, p. 101990, https://doi.org/10.1016/j.jcyt.2025.09.013.